SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 157 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $65,000 | -47.2% | 47,445 | -13.4% | 0.00% | – |
Q3 2021 | $123,000 | -37.6% | 54,816 | +9.6% | 0.00% | – |
Q2 2021 | $197,000 | +43.8% | 50,037 | +16.3% | 0.00% | – |
Q1 2021 | $137,000 | -17.0% | 43,042 | -4.6% | 0.00% | – |
Q4 2020 | $165,000 | +114.3% | 45,141 | +140.6% | 0.00% | – |
Q3 2020 | $77,000 | +11.6% | 18,764 | -10.2% | 0.00% | – |
Q2 2020 | $69,000 | +6800.0% | 20,884 | +3710.9% | 0.00% | – |
Q1 2020 | $1,000 | -98.5% | 548 | -97.0% | 0.00% | – |
Q4 2019 | $67,000 | -44.2% | 18,412 | +27.7% | 0.00% | – |
Q3 2019 | $120,000 | +3.4% | 14,423 | +6.9% | 0.00% | – |
Q2 2019 | $116,000 | +157.8% | 13,498 | +218.6% | 0.00% | – |
Q1 2019 | $45,000 | +36.4% | 4,236 | +10.9% | 0.00% | – |
Q4 2018 | $33,000 | -99.4% | 3,821 | -98.7% | 0.00% | -100.0% |
Q3 2018 | $5,112,000 | +69.0% | 304,276 | +110.9% | 0.00% | +100.0% |
Q2 2018 | $3,024,000 | +10.4% | 144,282 | -15.3% | 0.00% | 0.0% |
Q1 2018 | $2,739,000 | -6.9% | 170,272 | +9.7% | 0.00% | -33.3% |
Q4 2017 | $2,941,000 | +32.4% | 155,224 | -1.7% | 0.00% | +50.0% |
Q3 2017 | $2,221,000 | +163.5% | 157,850 | +39.6% | 0.00% | +100.0% |
Q2 2017 | $843,000 | +15.6% | 113,035 | +0.7% | 0.00% | 0.0% |
Q1 2017 | $729,000 | +107.1% | 112,208 | +24.7% | 0.00% | – |
Q4 2016 | $352,000 | -35.3% | 90,000 | -22.7% | 0.00% | -100.0% |
Q3 2016 | $544,000 | -29.6% | 116,411 | -0.9% | 0.00% | 0.0% |
Q2 2016 | $773,000 | +3.5% | 117,461 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $747,000 | +6.7% | 117,461 | +1.2% | 0.00% | 0.0% |
Q4 2015 | $700,000 | -16.2% | 116,050 | -16.9% | 0.00% | 0.0% |
Q3 2015 | $835,000 | -13.4% | 139,689 | -0.8% | 0.00% | 0.0% |
Q2 2015 | $964,000 | +5.8% | 140,823 | -6.1% | 0.00% | 0.0% |
Q1 2015 | $911,000 | -16.0% | 150,000 | -4.1% | 0.00% | 0.0% |
Q4 2014 | $1,084,000 | -91.2% | 156,486 | -89.7% | 0.00% | -92.9% |
Q3 2014 | $12,335,000 | +1.2% | 1,515,394 | +1.0% | 0.01% | 0.0% |
Q2 2014 | $12,194,000 | +592.8% | 1,499,834 | +567.9% | 0.01% | +600.0% |
Q1 2014 | $1,760,000 | -11.5% | 224,543 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $1,988,000 | +3387.7% | 224,543 | +3194.8% | 0.00% | – |
Q3 2013 | $57,000 | +29.5% | 6,815 | +14.8% | 0.00% | – |
Q2 2013 | $44,000 | – | 5,938 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |